Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 253

1.

Treatment and outcomes of infections by methicillin-resistant Staphylococcus aureus at an ambulatory clinic.

Szumowski JD, Cohen DE, Kanaya F, Mayer KH.

Antimicrob Agents Chemother. 2007 Feb;51(2):423-8. Epub 2006 Nov 20.

2.

Community-onset methicillin-resistant Staphylococcus aureus in an urban HIV clinic.

Skiest D, Brown K, Hester J, Moore T, Crosby C, Mussa HR, Hoffman-Roberts H, Cooper T.

HIV Med. 2006 Sep;7(6):361-8.

3.

Epidemiology and outcomes of community-associated methicillin-resistant Staphylococcus aureus infection.

Davis SL, Perri MB, Donabedian SM, Manierski C, Singh A, Vager D, Haque NZ, Speirs K, Muder RR, Robinson-Dunn B, Hayden MK, Zervos MJ.

J Clin Microbiol. 2007 Jun;45(6):1705-11. Epub 2007 Mar 28.

4.

Prospective comparison of methicillin-susceptible and methicillin-resistant community-associated Staphylococcus aureus infections in hospitalized patients.

Skiest DJ, Brown K, Cooper TW, Hoffman-Roberts H, Mussa HR, Elliott AC.

J Infect. 2007 May;54(5):427-34. Epub 2006 Oct 27.

PMID:
17070598
5.

Diagnostic and therapeutic evaluation of community-acquired methicillin-resistant Staphylococcus Aureus (MRSA) skin and soft tissue infections in the emergency department.

Walraven CJ, Lingenfelter E, Rollo J, Madsen T, Alexander DP.

J Emerg Med. 2012 Apr;42(4):392-9. doi: 10.1016/j.jemermed.2011.03.009. Epub 2011 Apr 27.

PMID:
21524884
6.
7.

Emergence of community-acquired methicillin-resistant Staphylococcus aureus USA 300 clone as the predominant cause of skin and soft-tissue infections.

King MD, Humphrey BJ, Wang YF, Kourbatova EV, Ray SM, Blumberg HM.

Ann Intern Med. 2006 Mar 7;144(5):309-17.

PMID:
16520471
8.

Dose of trimethoprim-sulfamethoxazole to treat skin and skin structure infections caused by methicillin-resistant Staphylococcus aureus.

Cadena J, Nair S, Henao-Martinez AF, Jorgensen JH, Patterson JE, Sreeramoju PV.

Antimicrob Agents Chemother. 2011 Dec;55(12):5430-2. doi: 10.1128/AAC.00706-11. Epub 2011 Sep 19.

9.
10.

Skin and soft-tissue infections caused by community-acquired methicillin-resistant Staphylococcus aureus.

Stryjewski ME, Chambers HF.

Clin Infect Dis. 2008 Jun 1;46 Suppl 5:S368-77. doi: 10.1086/533593. Review.

PMID:
18462092
12.

Increased US emergency department visits for skin and soft tissue infections, and changes in antibiotic choices, during the emergence of community-associated methicillin-resistant Staphylococcus aureus.

Pallin DJ, Egan DJ, Pelletier AJ, Espinola JA, Hooper DC, Camargo CA Jr.

Ann Emerg Med. 2008 Mar;51(3):291-8. doi: 10.1016/j.annemergmed.2007.12.004. Epub 2008 Jan 28.

PMID:
18222564
13.

Increasing clindamycin resistance among methicillin-resistant Staphylococcus aureus in 57 northeast United States military treatment facilities.

Braun L, Craft D, Williams R, Tuamokumo F, Ottolini M.

Pediatr Infect Dis J. 2005 Jul;24(7):622-6.

PMID:
15999004
14.

Has the emergence of community-associated methicillin-resistant Staphylococcus aureus increased trimethoprim-sulfamethoxazole use and resistance?: a 10-year time series analysis.

Wood JB, Smith DB, Baker EH, Brecher SM, Gupta K.

Antimicrob Agents Chemother. 2012 Nov;56(11):5655-60. doi: 10.1128/AAC.01011-12. Epub 2012 Aug 20.

15.

Community-onset methicillin-resistant Staphylococcus aureus skin and soft-tissue infections: impact of antimicrobial therapy on outcome.

Ruhe JJ, Smith N, Bradsher RW, Menon A.

Clin Infect Dis. 2007 Mar 15;44(6):777-84. Epub 2007 Feb 1.

PMID:
17304447
16.

High prevalence of methicillin-resistant Staphylococcus aureus in emergency department skin and soft tissue infections.

Frazee BW, Lynn J, Charlebois ED, Lambert L, Lowery D, Perdreau-Remington F.

Ann Emerg Med. 2005 Mar;45(3):311-20.

PMID:
15726056
17.

Changes in prescriptive practices in skin and soft tissue infections associated with the increased occurrence of community acquired methicillin resistant Staphylococcus aureus.

Meddles-Torres C, Hu S, Jurgens C.

J Infect Public Health. 2013 Dec;6(6):423-30. doi: 10.1016/j.jiph.2013.04.010. Epub 2013 Jun 15.

18.

The benefit of empiric treatment for methicillin-resistant Staphylococcus aureus.

Chuck EA, Frazee BW, Lambert L, McCabe R.

J Emerg Med. 2010 Jun;38(5):567-71. doi: 10.1016/j.jemermed.2007.11.037. Epub 2008 Jun 2.

PMID:
18514468
20.

Management and outcome of children with skin and soft tissue abscesses caused by community-acquired methicillin-resistant Staphylococcus aureus.

Lee MC, Rios AM, Aten MF, Mejias A, Cavuoti D, McCracken GH Jr, Hardy RD.

Pediatr Infect Dis J. 2004 Feb;23(2):123-7.

PMID:
14872177

Supplemental Content

Support Center